These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35521773)

  • 1. Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma.
    Zhang Z; Li M; Wang J; Liu M; Chen H; Lou Y; Wang Y; Sun Q; Zhu D; Li P; Bi Y
    Endocr Relat Cancer; 2022 May; 29(7):403-413. PubMed ID: 35521773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of B7 family checkpoint proteins in cervical cancer.
    Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J
    Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer.
    Zong L; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma.
    Wang Y; Deng J; Wang L; Zhou T; Yang J; Tian Z; Yang J; Chen H; Tang X; Zhao S; Zhou L; Tong A; Xu J
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the immune checkpoint VISTA in breast cancer.
    Zong L; Mo S; Yu S; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Aug; 69(8):1437-1446. PubMed ID: 32266446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors.
    Mo S; Zong L; Chen X; Ban X; Li M; Lu Z; Yu S; Chen J
    Arch Pathol Lab Med; 2023 Feb; 147(2):193-201. PubMed ID: 35671167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
    Muller S; Victoria Lai W; Adusumilli PS; Desmeules P; Frosina D; Jungbluth A; Ni A; Eguchi T; Travis WD; Ladanyi M; Zauderer MG; Sauter JL
    Mod Pathol; 2020 Feb; 33(2):303-311. PubMed ID: 31537897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma.
    Landwehr LS; Altieri B; Sbiera I; Remde H; Kircher S; Olabe J; Sbiera S; Kroiss M; Fassnacht M
    J Clin Endocrinol Metab; 2024 Aug; 109(9):2325-2334. PubMed ID: 38415841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer.
    Zong L; Mo S; Sun Z; Lu Z; Yu S; Chen J; Xiang Y
    Mod Pathol; 2022 Feb; 35(2):266-273. PubMed ID: 34493823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of immune check point protein PDL-1 in hepatocellular carcinoma denotes its prognostic significance and association with survival.
    Helmy DO; Khattab F; Hegazy AE; Sabry RM
    J Immunoassay Immunochem; 2023 May; 44(3):213-228. PubMed ID: 36281205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival.
    Kuklinski LF; Yan S; Li Z; Fisher JL; Cheng C; Noelle RJ; Angeles CV; Turk MJ; Ernstoff MS
    Cancer Immunol Immunother; 2018 Jul; 67(7):1113-1121. PubMed ID: 29737375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer.
    Villarroel-Espindola F; Yu X; Datar I; Mani N; Sanmamed M; Velcheti V; Syrigos K; Toki M; Zhao H; Chen L; Herbst RS; Schalper KA
    Clin Cancer Res; 2018 Apr; 24(7):1562-1573. PubMed ID: 29203588
    [No Abstract]   [Full Text] [Related]  

  • 13. Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells.
    Sahinli H; Akyürek N; Yılmaz M; Kandemir O; Duran AO; Kulaçoǧlu S; Uçar G; Acar E; Özet A; Öksüzoǧlu OBÇ; Özdemir NY
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S43-S47. PubMed ID: 33380650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma.
    Long L; Zhang L; Yang Y; Zhou Y; Chen H
    Immunotherapy; 2022 Apr; 14(6):419-431. PubMed ID: 35187955
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.
    Xie S; Huang J; Qiao Q; Zang W; Hong S; Tan H; Dong C; Yang Z; Ni L
    Cancer Immunol Immunother; 2018 Nov; 67(11):1685-1694. PubMed ID: 30128738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
    Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y
    J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma.
    Wang LC; Wang YL; He B; Zheng YJ; Yu HC; Liu ZY; Fan RR; Zan X; Liang RC; Wu ZP; Tang X; Wang GQ; Xu JG; Zhou LX
    Clin Immunol; 2022 Dec; 245():109178. PubMed ID: 36368642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma.
    He HX; Gao Y; Fu JC; Zhou QH; Wang XX; Bai B; Li PF; Huang C; Rong QX; Ping LQ; He YX; Mao JY; Chen X; Huang HQ
    Oncoimmunology; 2021 Apr; 10(1):1907059. PubMed ID: 33889438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
    Liang J; Liu Z; Pei T; Xiao Y; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Yin X; Chen N; Wei X; Lu Y; Zhu Y
    Dis Markers; 2020; 2020():5354825. PubMed ID: 31998416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.
    Wu L; Deng WW; Huang CF; Bu LL; Yu GT; Mao L; Zhang WF; Liu B; Sun ZJ
    Cancer Immunol Immunother; 2017 May; 66(5):627-636. PubMed ID: 28236118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.